Skip to main content

Table 3 General features of the studies which were included in this analysis

From: Long-term cardiovascular outcomes of biodegradable polymer drug eluting stents in patients with diabetes versus non-diabetes mellitus: a meta-analysis

Studies

No of DM participants (n)

No of non-DM participants (n)

Type of stents

Type of study

Period of enrollment (years)

Iglesias2019

257

806

BP-SES

Trial

2012–2013

Lee2017

306

693

BP-BES

Observational

2010–2012

Lenz2021

376

923

BP-SES

Trial

2007–2008

Li2012

440

1637

BP-SES

Trial

2006

Rola2021

59

110

BP-DES

Observational

2015–2020

Tang2018

421

1151

BP-DES

Observational

2013

Wiermer2017

888

2179

BP-DES

Observational

2008–2009

  1. Abbreviations: DM: Diabetes mellitus; BP-SES: Biodegradable polymer sirolimus eluting stents; BP-BES: Biodegradable polymer biolimus eluting stents; BP-DES: Biodegradable polymer drug eluting stents